Gary R Duckwiler Selected Research

Thrombectomy

1/2018	Early Blood-Brain Barrier Disruption after Mechanical Thrombectomy in Acute Ischemic Stroke.
6/2016	Mechanical thrombectomy for acute ischemic stroke with cerebral microbleeds.
11/2015	New Cerebral Microbleeds After Mechanical Thrombectomy for Large-Vessel Occlusion Strokes.
6/2015	Carotid I's, L's and T's: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke.
7/2014	Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes.
10/2012	Impact of Merci device fracture on clinical outcome of acute ischemic stroke after mechanical thrombectomy.
7/2012	Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke.
5/2011	CT and MRI early vessel signs reflect clot composition in acute stroke.
12/2010	Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy.
6/2010	Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary R Duckwiler Research Topics

Disease

17	Ischemic Stroke 01/2018 - 06/2003
12	Stroke (Strokes) 10/2022 - 06/2003
8	Aneurysm (Aneurysms) 10/2023 - 01/2003
8	Brain Ischemia (Cerebral Ischemia) 03/2017 - 12/2004
6	Intracranial Aneurysm (Cerebral Aneurysm) 02/2017 - 04/2002
5	Hemorrhage 01/2022 - 04/2007
4	Pathologic Constriction (Stenosis) 10/2023 - 04/2002
4	Embolism (Embolus) 07/2014 - 12/2004
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2016 - 05/2010
3	Thrombosis (Thrombus) 06/2015 - 04/2002
2	Epistaxis (Nosebleed) 10/2023 - 01/2022
2	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021 - 02/2017
2	Arteriovenous Fistula 02/2017 - 06/2006
2	Hematoma 07/2012 - 02/2012
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2012 - 12/2010
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2010 - 11/2006
2	Infarction (Infarctions) 05/2010 - 10/2009
1	Varicose Veins (Varicose Vein) 01/2023
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 02/2020
1	Ischemia 01/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 03/2017
1	Neoplasms (Cancer) 02/2017
1	Rupture 06/2016
1	Leukoaraiosis 07/2012
1	Vertebrobasilar Insufficiency 02/2012
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2012
1	Hypertension (High Blood Pressure) 12/2010
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 10/2010
1	Cerebral Infarction 05/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2009
1	Cerebral Hemorrhage 01/2009
1	Hyperlipidemias (Hyperlipidemia) 01/2009

Drug/Important Bio-Agent (IBA)

3	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2022 - 06/2003
2	Indicators and Reagents (Reagents)IBA 02/2012 - 11/2003
2	Phenobarbital (Luminal)FDA Link 01/2012 - 05/2010
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2023
1	IronIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	PlatinumIBA 02/2017
1	Warfarin (Coumadin)FDA LinkGeneric 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012
1	antineoplaston A10 (A 10)IBA 01/2012
1	EnbucrilateIBA 10/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009
1	3-hydroxy-7-methylcholanoic acid (HMCA)IBA 11/2003
1	PapaverineIBA 01/2003
1	Abciximab (ReoPro)FDA Link 04/2002

Therapy/Procedure

16	Therapeutics 10/2022 - 04/2002
15	Thrombectomy 01/2018 - 04/2007
6	Stents 06/2016 - 04/2002
4	Endovascular Procedures 10/2023 - 01/2009
3	Ligation 10/2023 - 06/2006
3	Catheters 10/2023 - 11/2003
2	Cerebral Revascularization 10/2023 - 12/2009
2	Embolectomy 01/2009 - 12/2004
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Therapeutic Embolization 01/2021
1	Off-Label Use 01/2012
1	Length of Stay 10/2009
1	Retreatment 01/2008
1	Aftercare (After-Treatment) 01/2008
1	Intravenous Infusions 04/2002